Anna Arnal-Estapé

7PUBLICATIONS
47CO-AUTHORS
Molecular targetsCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 15, 2024
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.

Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel

|Feb 10, 2024
Patient-Derived Models of Cancer in the NCI PDMC Consortium: Selection, Pitfalls, and Practical Recommendations.

Amber N Habowski, Deepthi P Budagavi, Sandra D Scherer

|Dec 12, 2022
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer.

Sally J Adua, Anna Arnal-Estapé, Minghui Zhao

|Aug 31, 2022
Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation.

Wesley L Cai, Jocelyn Fang-Yi Chen, Huacui Chen

|Mar 12, 2020
Tumor progression and chromatin landscape of lung cancer are regulated by the lineage factor GATA6.

Anna Arnal-Estapé, Wesley L Cai, Alexandra E Albert

Pageof 2